Clinical Trials Logo

Clinical Trial Summary

The single-center, randomized, open-label, three-period crossover bioavailability study will include 21 subjects who will test three CoQ10 formulations. Subjects will test 3 formulations of single dose CoQ10 within first 3 weeks to assess bioavailability, which will be followed with 2 weeks of continuous administration of one of study formulations to demonstrate and assesse multiple-dose profile of CoQ10.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03284814
Study type Interventional
Source Nutrition Institute, Slovenia
Contact
Status Completed
Phase N/A
Start date August 29, 2017
Completion date October 20, 2017

See also
  Status Clinical Trial Phase
Completed NCT04780074 - Comparative Single-dose Bioavailability Study of Different CoQ10 Formulations N/A